use
overlap
synthet
peptid
cover
amino
acid
sequenc
capsid
protein
rubella
viru
cell
clone
rl
rl
al
al
al
isol
rubella
seroposit
donor
react
strongli
rubella
capsid
peptid
residu
residu
cl
residu
respect
prolifer
cytotox
assay
truncat
peptid
residu
residu
cl
e
residu
shown
involv
directli
cell
determin
cl
respect
genet
restrict
cell
clone
analyz
use
human
cell
line
variou
hladr
phenotyp
target
andor
antigenpres
cell
cytotox
assay
andor
prolifer
assay
result
indic
recognit
peptid
byt
cell
clone
rl
associ
molecul
hla
restrict
element
respons
cell
clone
al
al
al
react
peptid
cl
molecul
howev
may
crossrecognit
cell
clone
al
drl
subtyp
academ
press
nc
rubella
viru
rv
common
human
pathogen
rv
infect
pregnanc
may
result
spontan
abort
congenit
defect
viral
persist
newborn
sandra
et
al
sever
live
attenu
rubella
vaccin
introduc
sinc
petfin
immun
infant
suscept
women
childbear
age
rv
standard
public
health
measur
howev
still
major
medic
concern
reinfect
vaccine
wildtyp
rv
risk
congenit
infect
fetu
rubellaassoci
arthriti
aris
vaccin
chantler
et
fraser
et
sandra
et
clear
requir
develop
noninfecti
rubella
vaccin
recent
studi
indic
synthet
peptid
function
inexpens
noninfecti
candid
vaccin
infecti
diseas
milich
import
know
major
human
cell
site
select
short
synthet
peptid
compon
potenti
subunit
vaccin
evid
mani
viru
studi
indic
central
role
rather
cell
induct
specif
immun
respons
viru
antigen
subunit
peptid
good
et
al
korner
et
fayol
et
known
cell
rec
reprint
request
address
ogniz
foreign
antigen
ag
nativ
form
small
peptid
produc
process
ag
within
agpres
cell
apc
present
cell
surfac
complex
major
histocompat
complex
mhc
class
ii
molecul
milich
et
al
berzofski
thu
identifi
small
peptid
epitop
within
primari
sequenc
candid
vaccin
ag
defin
genet
restrict
recogn
lymphocyt
could
facilit
effect
vaccin
design
milich
et
wallac
et
al
rv
envelop
rna
viru
two
envelop
glycoprotein
el
virion
surfac
capsid
protein
rna
core
okerblom
et
al
synthes
synthet
peptid
compris
approxim
amino
acid
sequenc
structur
protein
el
peptid
peptid
c
peptid
rv
strain
clark
et
initi
seri
experi
search
peptidespecif
cell
respons
individu
natur
infect
rv
show
c
peptid
residu
residu
residu
cl
residu
induc
signific
prolifer
cell
shortterm
cultur
cell
line
rvseroposit
donor
ou
et
cell
clone
use
studi
initi
establish
cell
line
two
rv
seroposit
donor
ou
et
total
clone
isol
method
total
x
cell
clone
test
prolif
respons
synthetrc
peptid
final
concentr
pgml
presenc
yirradi
rad
autolog
pbmc
x
apc
result
present
mean
cpm
obtain
triplic
determin
underlin
number
repres
signific
cell
prolifer
valu
limit
dilut
celi
et
al
b
rv
specif
test
prolifer
assay
ou
et
al
identifi
capac
cell
clone
recogn
cell
epitop
structur
protein
rv
respons
synthet
peptid
test
prolifer
assay
base
posit
respons
uvinactiv
rv
individu
c
peptid
clone
select
studi
cell
clone
rl
rl
isol
orient
donor
rm
react
strongli
peptid
residu
tabl
cell
clone
al
al
al
isol
caucasian
donor
clone
al
respond
residu
clone
al
react
cl
residu
tabl
surfac
marker
analysi
cell
clone
show
cell
data
shown
demonstr
cell
clone
probabl
helper
cell
termin
target
cell
incub
medium
alon
uvinactiv
ebv
peptid
rv
kill
cell
margin
lyse
doseindepend
manner
data
shown
indic
cytotox
respons
inde
agspecif
cytotox
activ
capsid
peptidespecif
cell
clone
studi
use
autolog
epsteinbarr
virustransform
b
cell
line
ebvbl
cell
target
standard
releas
assay
celi
et
al
strong
specif
cytotox
respons
cell
clone
rl
alo
al
observ
target
cell
preincub
either
rv
peptid
cl
respect
fig
result
indic
cell
clone
rl
abil
kill
autolog
ebvbl
target
cell
incub
peptid
cell
clone
al
al
al
cytotox
activ
autolog
ebvbl
cell
express
peptid
cl
dein
order
identifi
minim
antigen
peptid
cell
clone
nest
set
truncat
peptid
within
relev
region
c
determin
prepar
test
prolifer
releas
assay
peptid
residu
residu
residu
equal
effici
prolifer
assay
compar
antigen
peptid
residu
residu
shortest
peptid
could
stimul
cell
clone
rl
tabl
result
obtain
cytotox
assay
cell
clone
rl
rl
found
parallel
result
prolifer
assay
data
shown
thu
cell
clone
display
cytotox
activ
autolog
ebvbl
target
express
epitop
besid
peptid
residu
truncat
peptid
residu
stimul
prolif
respons
cell
clone
al
tabl
peptid
residu
residu
residu
residu
gave
neg
result
tabl
cytotox
respons
al
clone
truncat
peptid
found
similar
prolifer
respons
data
shown
cell
clone
al
al
respond
cl
peptid
antigen
cl
f
residu
prolifer
assay
tabl
cl
f
shortest
cl
truncat
peptid
stimul
cell
clone
signific
cell
prolifer
respons
tabl
releas
assay
cell
clone
al
al
cytotox
autolog
ebvbl
target
cell
expressingpeptidescl
clla
cllb
cllc
andcll
cl
cl
f
data
shown
result
suggest
differ
cell
recognit
cl
epitop
two
cell
function
assay
appear
induct
cytotox
respons
cell
clone
c
bind
target
requir
residu
tter
cl
sequenc
interest
determin
whether
cell
clone
restrict
differ
hla
determin
mab
specif
monomorph
region
hlaabc
hladr
hladq
antigen
total
x
cell
clone
test
prolif
respons
synthetrc
peptid
final
concentr
pgml
presenc
apc
rirradi
autolog
ebvbc
cell
amino
acid
sequenc
peptid
deriv
nucleotid
sequenc
correspond
c
protein
rv
c
underlin
sequenc
indic
shortest
peptid
signific
cell
prolifer
responsor
cell
clone
shown
parenthes
test
abil
block
present
cl
peptid
epitop
autolog
peripher
blood
mononuclear
cell
pbmc
stimul
clone
rlo
rl
peptid
clone
al
peptid
clone
al
peptid
cl
clearli
inhibit
presenc
antihladr
dq
mab
van
voorhi
et
antihladr
mab
lampson
levi
presenc
antihlaabc
mab
brodskyand
parham
antihiadc
mab
gile
et
al
data
shown
result
indic
cell
clone
hladrrestrict
order
complet
detail
analysi
genet
restrict
capsid
peptid
specif
cell
clone
use
ebvbl
differ
hla
phenotyp
apc
prolifer
assay
tabl
target
cytotox
assay
six
homozyg
human
hla
phenotyp
cell
line
hcl
cell
use
target
cell
releas
assay
studi
tabl
character
restrict
element
cell
clone
rl
establish
use
prolifer
releas
assay
peptid
residu
present
ebvbl
rm
other
prolifer
assay
tabl
ebvbl
rm
autolog
b
cell
line
cell
clone
rl
import
differ
ebvbl
ebvbl
former
share
hla
phenotyp
rm
tabl
similar
result
observ
releas
assay
five
ebvbl
use
target
cell
cell
clone
recogn
rm
target
ms
target
data
shown
result
suggest
restrict
molecul
use
present
determin
drwsassoci
haplotyp
order
defin
restrict
molecul
respons
cell
clone
al
determin
test
cytotox
respons
cell
clone
al
six
hcl
five
ebvbl
previous
incub
peptid
result
demonstr
cell
clone
al
recogn
hcl
priess
tabl
ebvbl
cm
mt
data
shown
share
hla
phenotyp
ebvbl
autolog
ebvbl
cell
clone
al
result
prolifer
assay
use
ebvbl
apc
correl
well
result
cytotox
assay
cell
clone
al
respond
peptid
peptid
present
ebvbl
cm
hc
ms
n
mt
express
phenotyp
rm
lm
data
shown
henc
restrict
element
present
peptid
epitop
cell
clone
al
restrict
specif
cell
clone
al
cl
determin
analyz
use
releas
assay
six
hcl
ebvbl
use
target
cell
clone
al
result
show
cell
clone
strongli
lytic
ebvbl
hcl
priess
share
hla
phenotyp
autolog
ebvbl
fig
clone
use
effector
four
ebvbl
cell
previous
incub
cl
peptid
use
target
cell
cytotox
assay
result
indic
cell
clone
al
cytotox
target
ebvbl
cm
mt
express
phenotyp
target
rm
fig
result
demonstr
genet
restrict
molecul
cell
clone
al
al
prolifer
respons
cell
clone
al
al
howev
ebvbl
lm
whose
dr
phenotyp
drl
like
cm
hc
ms
aj
abl
present
cl
determin
data
shown
order
test
abil
ebvbl
lm
present
cl
cell
clone
al
use
ebvbl
lm
cell
target
releas
assay
result
indic
ebvbl
lm
abl
elicit
cytotox
respons
cell
clone
al
peptid
cl
similar
elicit
target
cell
aj
fig
nd
nd
nd
nd
clone
cell
x
cultur
hr
presenc
rirradi
rad
ebvbl
cell
x
apc
hlatyp
donor
without
peptid
ml
thymidin
ad
last
hr
cultur
result
express
mean
cpm
triplic
cultur
b
apc
rm
autolog
ebvbl
cgspecif
clone
cpm
cultur
without
c
peptid
cpm
nd
test
two
model
propos
predict
studi
rothbard
taylor
point
identifi
amino
acid
sequenc
antigen
involv
exist
acid
sequenc
motif
cell
recognit
de
lisi
berzofski
larg
number
cell
antigen
determin
consispropos
larg
proport
lymphocyt
aptent
first
model
found
pearto
react
ahel
amphipath
structur
cl
e
effici
induc
proliferacontain
within
amino
acid
sequenc
antit
cytotox
respons
correspond
gen
protein
margalit
et
al
hand
cl
lreactiv
cell
clone
locat
b
cell
line
use
target
incub
without
peptid
ml
overnight
addit
cell
b
cytotox
determin
use
cell
clone
al
effectorkarget
ratio
peak
region
ahelix
index
within
cl
peptid
sequenc
accord
profil
ahelix
pturn
hydrophil
c
protein
rv
ou
et
analyz
cell
motif
second
model
structur
within
cl
sequenc
ou
et
locat
region
two
cell
motif
structur
contain
acid
cell
motif
structur
cl
e
sequenc
contain
half
acid
structur
although
antigen
predict
method
popular
predict
locat
viral
epitop
result
indic
latter
model
may
achiev
high
level
correct
predict
question
hla
class
ii
polymorph
epitop
select
clearli
import
issu
design
subunit
synthet
vaccin
genet
divers
human
popul
hla
restrict
pattern
cell
clone
al
al
complex
clone
mention
besid
six
ebvbl
phenotyp
ebvbl
lm
drl
phenotyp
could
also
present
peptid
cl
stimul
clone
al
al
prolifer
respons
data
shown
similar
genet
restrict
hla
shown
cytotox
assay
fig
interestingli
cell
clone
al
cytotox
target
u
mt
phenotyp
lm
drl
phenotyp
present
cl
determin
fig
result
suggest
crossrecognit
cell
clone
drl
subtyp
phenomenon
consist
report
regard
hla
restrict
human
cell
clone
ree
et
lamb
et
al
howev
contrast
cell
clone
al
exhibit
specif
cytotox
respons
hcl
priess
phenotyp
express
cl
hcl
maja
hladrl
phenotyp
fig
may
differ
structur
antigenbind
site
drl
molecul
hcl
maja
ebvbl
lm
three
differ
drl
subtyp
amino
acid
substitut
put
peptidebind
site
residu
p
domain
identifi
marsh
bodmer
differ
drl
subtyp
may
result
cl
peptid
bind
suffici
affin
requir
conform
drl
molecul
hcl
maja
stimul
cell
clone
crossrecognit
cell
clone
al
drl
subtyp
similar
result
report
studi
human
cell
recognit
influenza
viru
brett
et
al
examin
fine
specif
cell
recognit
protein
antigen
virus
parasit
human
murin
system
reveal
multipl
distinct
tcell
site
among
individu
differ
hla
phenotyp
panel
congen
strain
due
limit
impos
cell
antigen
recognit
mhc
restrict
becom
appar
number
cell
site
requir
ensur
synthet
vaccin
engag
major
outbr
popul
present
number
short
synthet
cell
site
within
particular
structur
may
econom
feasibl
way
accomplish
task
milich
recognit
cl
cell
clone
associ
frequent
occur
hla
dr
allel
among
orient
also
common
among
caucasian
furthermor
also
frequent
among
orient
gile
capra
recent
test
cell
line
rv
patient
healthi
donor
differ
hla
phenotyp
use
synthet
c
peptid
result
demonstr
cl
recogn
cell
line
higher
frequenc
peptid
unpublish
data
cell
determin
may
select
candid
cell
site
futur
rv
vaccin
develop
